NCT01468012View on ClinicalTrials.gov

Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

December 31, 2015

Conditions
Cocaine Dependence
Interventions
DRUG

levodopa carbidopa and entacapone (LCE)

400mg/100mg/200mg, twice daily

DRUG

Placebo

matched placebo for LCE condition dosed twice daily

Trial Locations (1)

10032

STARS, New York

All Listed Sponsors
lead

New York State Psychiatric Institute

OTHER

NCT01468012 - Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence | Biotech Hunter | Biotech Hunter